- Report
- January 2026
- 373 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 186 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 381 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 283 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 390 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 270 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 184 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 184 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 286 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 289 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 296 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 183 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 193 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 390 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 381 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 121 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 474 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 274 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more